BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Tamoxifen, rs6983267, NEUROG3, Response to oxidative stress, Diabetes mellitus, Lung)
Bookmark Forward

QuickView for PRKAR1A (gene)


Body Atlas

Most Correlated Tissues

  1. Eosinophil of peripheral blood
  2. Leukocyte (polymorphonuclear) of peripheral blood
  3. Thalamus lateral nuclei
  4. Substantia nigra pars compacta
  5. Frontal cortex
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Malignant tumor of muscle
  2. Adrenal cancer
  3. Ataxia-telangiectasia syndrome
  4. Mycobacteriosis
  5. Chronic fatigue syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Oleandomycin
  2. Metolazone
  3. phthalylsulfathiazole
  4. piperacetazine
  5. Quipazine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. CDHR2
  2. PRKAR1A
  3. BCL3
  4. ATM
  5. PRKCD
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. MANAGEMENT OF ENDOCRINE DISEASE: Carney complex: clinical and genetic update 20 years after the iden…
  2. PRKAR1A deficiency impedes hypertrophy and reduces heart size.
  3. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Disti…
  4. PRKAR1A mutation causing pituitary-dependent Cushing disease in a patient with Carney complex.
  5. Identification of a PRKAR1A mutation (c.491_492delTG) in familial cardiac myxoma: A case report.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)
  2. Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (…
  3. Adrenal Hyperplasia Among Young People With PCOS
  4. A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Ce…
  5. Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors…
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.